176 related articles for article (PubMed ID: 30543782)
1. Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states.
Shoieb SM; El-Sherbeni AA; El-Kadi AOS
Chem Biol Interact; 2019 Feb; 299():140-150. PubMed ID: 30543782
[TBL] [Abstract][Full Text] [Related]
2. Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs.
Gerges SH; Alammari AH; El-Ghiaty MA; Isse FA; El-Kadi AOS
Can J Physiol Pharmacol; 2023 Aug; 101(8):425-436. PubMed ID: 37220651
[TBL] [Abstract][Full Text] [Related]
3. Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids.
Helal SA; Gerges SH; El-Kadi AOS
Drug Metab Rev; 2024 Feb; 56(1):31-45. PubMed ID: 38358327
[TBL] [Abstract][Full Text] [Related]
4. Roles of hydroxyeicosatetraenoic acids in diabetes (HETEs and diabetes).
Dong L; Wang H; Chen K; Li Y
Biomed Pharmacother; 2022 Dec; 156():113981. PubMed ID: 36411651
[TBL] [Abstract][Full Text] [Related]
5. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
6. The enantioselective separation and quantitation of the hydroxy-metabolites of arachidonic acid by liquid chromatography - tandem mass spectrometry.
Isse FA; Alammari AH; El-Sherbeni AA; Brocks DR; El-Kadi AOS
Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106701. PubMed ID: 36528330
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism.
El-Sherbeni AA; El-Kadi AO
Mol Pharm; 2016 Apr; 13(4):1278-88. PubMed ID: 26918316
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-derived renal HETEs: storage and release.
Carroll MA; Balazy M; Huang DD; Rybalova S; Falck JR; McGiff JC
Kidney Int; 1997 Jun; 51(6):1696-702. PubMed ID: 9186856
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides.
Carroll MA; Balazy M; Margiotta P; Huang DD; Falck JR; McGiff JC
Am J Physiol; 1996 Oct; 271(4 Pt 2):R863-9. PubMed ID: 8897975
[TBL] [Abstract][Full Text] [Related]
11. Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As.
El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2014 Sep; 42(9):1498-507. PubMed ID: 24969701
[TBL] [Abstract][Full Text] [Related]
12. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes.
Xu F; Falck JR; Ortiz de Montellano PR; Kroetz DL
J Pharmacol Exp Ther; 2004 Mar; 308(3):887-95. PubMed ID: 14634044
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers.
Schlezinger JJ; Parker C; Zeldin DC; Stegeman JJ
Arch Biochem Biophys; 1998 May; 353(2):265-75. PubMed ID: 9606961
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.
Powell WS; Rokach J
Biochim Biophys Acta; 2015 Apr; 1851(4):340-55. PubMed ID: 25449650
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy.
Isse FA; El-Sherbeni AA; El-Kadi AOS
Drug Metab Rev; 2022 May; 54(2):141-160. PubMed ID: 35306928
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450/NADPH-dependent biosynthesis of 5,6-trans-epoxyeicosatrienoic acid from 5,6-trans-arachidonic acid.
Roy U; Joshua R; Stark RL; Balazy M
Biochem J; 2005 Sep; 390(Pt 3):719-27. PubMed ID: 15916533
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone.
Harder DR; Campbell WB; Roman RJ
J Vasc Res; 1995; 32(2):79-92. PubMed ID: 7537544
[TBL] [Abstract][Full Text] [Related]
19. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation.
Kroetz DL; Xu F
Annu Rev Pharmacol Toxicol; 2005; 45():413-38. PubMed ID: 15822183
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo.
Chu ZM; Croft KD; Kingsbury DA; Falck JR; Reddy KM; Beilin LJ
Clin Sci (Lond); 2000 Mar; 98(3):277-82. PubMed ID: 10677385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
